✦ LIBER ✦
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study
✍ Scribed by John M. Bennett; Mary S. Young; Jane L. Liesveld; Elisabeth Paietta; Kenneth B. Miller; Hillard M. Lazarus; Robert D. Marsh; William R. Friedenberg; Hussain T. Saba; F. Ann Hayes; Gordon W. Dewald; Wolfgang Hiddemann; Jacob M. Rowe
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 39 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.